FDA 483 - EUROFINS ANIMAL HEALTH TESTING - November 08, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Eurofins Animal Health Testing in Indianapolis, IN, revealed significant deficiencies in their nonclinical laboratory study practices. The firm's quality assurance unit failed to properly document deviations from protocols and SOPs, and studies were not consistently conducted in accordance with approved protocols. Additionally, the quality assurance unit did not maintain an accurate and timely master schedule sheet for all nonclinical laboratory studies.
ID · 2c339bfe-d57d-4a9b-b26b-e3b3e7f69c73